Modulation of mouse cardiac function in vivo by eNOS and ANP

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Gyurko, Robert ^a   Kuhlencordt, Peter ^a   Fishman, Mark C ^a   Huang, Paul L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Contractility; Diastolic relaxation; Left Ventricle

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE RELAXATION; INOTROPISM; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0034069510     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.3.h971     Document Type: Article

References (49)

1. 1-adrenergic receptor-mediated regulation of β-adrenergic signaling. J. Biol. Chem. 272: 21253-21259, 1997.
2. Ausubel, R., R. Brent, R. Kingston, D. Moore, J. Seidman, J. Smith, and K. Struhl. Short Protocols in Molecular Biology (3rd ed.), Wiley, 1995, p. 4.22-4.25.
3. Balligand, J.-L., R. A. Kelly, P. A. Marsden, T. W. Smith, and T. Michel. Control of cardiac muscle function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90: 347-351, 1993.
4. Balligand, J.-L., L. Kobzik, X. Han, D. M. Kaye, L. Belhassen, D. S. O'Hara, R. A. Kelly, T. W. Smith, and T. Michel. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270: 14582-14586, 1995.
5. Balligand, J.-L., D. Ungureanu-Longrois, W. W. Simmons, D. Pimental, T. A. Malinski, M. Kapturczak, Z. Taha, C. J. Lowenstein, A. J. Davidoff, R. A. Kelly, T. W. Smith, and T. Michel. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J. Biol. Chem. 269: 27580-27588, 1994.
6. Calderone, A., C. Thaik, N. Takahashi, D. Chang, and W. Colucci. Nitric oxide, atrial nartriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J. Clin. Invest. 101: 812-818, 1998.
7. Choong, C. Y. Left ventricle V: diastolic function-its principles and evaluation. In: Principles and Practice of Echocardiography, edited by A. E. Weyman. Philadelphia, PA: Lea and Febiger, 1994, p. 721-726.
8. Clarkson, P., N. Wheeldon, C. Macleod, W. Coutie, and T. MacDonald. Acute effects of atrial natriuretic peptide an left ventricular diastolic function. Eur. Heart J. 16: 1710-1715, 1995.
9. Crosby, G., J. J. A. Marota, and P. L. Huang. Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase. Neuroscience 69: 1013-1017, 1995.
10. Crystal, G. J., X. Zhou, J. Gurevicius, and M. R. Salem. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts. Anesth. Analg. 87: 994-1001, 1998.
11. Dalkara, T., K. Irikura, Z. Huang, N. Panahian, and M. A. Moskowitz. Cerebrovascular responses under controlled and monitored physiological conditions in the anesthetized mouse. J. Cereb. Blood Flow Metab. 15: 631-638, 1995.
12. Endres, M., U. Laufs, Z. Huang, T. Nakamura, P. Huang, M. A. Moskowitz, and J. K. Liao. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 95: 8880-8885, 1998.
13. Fagan, K. A., B. W. Fouty, R. C. Tyler, K. G. Morris, Jr., L. K. Hepler, K. Sato, T. D. LeCras, S. H. Abman, H. D. Weinberger, P. L. Huang, I. F. McMurtry, and D. M. Rodman. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J. Clin. Invest. 103: 291-299, 1999.
14. Finkel, M., C. Oddis, T. Jacob, S. Watkins, B. Hattler, and R. Simmons. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389, 1992.
15. Finkel, M. S., C. V. Oddis, O. H. Mayer, B. G. Hattler, and R. L. Simmons. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J. Pharm. Exp. Ther. 272: 945-952, 1995.
16. Forstermann, U., J. S. Pollock, W. R. Tracey, and M. Nakane. Isoforms of nitric-oxide synthase: purification and regulation. Methods Enzymol. 233: 258-264, 1994.
17. 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J. Clin. Invest. 102: 1377-1384, 1998.
18. Grocott-Mason, R., P. Anning, H. Evans, M. J. Lewis, and A. M. Shah. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 267: H1804-H1813, 1994.
19. Han, X., I. Kubota, O. Feron, D. J. Opel, M. A. Arstall, Y. Y. Zhao, P. Huang, M. C. Fishman, T. Michel, and R. A. Kelly. Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 95: 6510-6515, 1998.
20. Hare, J. M., E. Loh, M. A. Creager, and W. S. Colucci. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 92: 2198-2203, 1995.
21. Hare, J. M., and J. S. Stamler. NOS: modulator, not mediator of cardiac performance. Nat. Med. 5: 273-274, 1999.
22. Huang, P. L., Z. Huang, H. Mashimo, K. D. Bloch, M. A. Moskowitz, J. A. Bevan, and M. C. Fishman. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
23. Huang, Z., K. Chen, P. L. Huang, S. P. Finklestein, and M. A. Moskowitz. bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice. Am. J. Physiol. Heart Circ. Physiol. 272: H1401-H1405, 1997.
24. Huang, Z., P. L. Huang, N. Panahian, T. Dalkara, M. C. Fishman, and M. A. Moskowitz. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265: 1883-1885, 1994.
25. ω-L-arginine methylester on the threshold for isoflurane anesthesia. Anesthesiology 83: 101-108, 1995.
26. Irikura, K., P. L. Huang, J. Ma, W. S. Lee, T. Dalkara, M. C. Fishman, T. M. Dawson, S. H. Snyder, and M. A. Moskowitz. Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proc. Natl. Acad. Sci. USA 92: 6823-6827, 1995.
27. Kanai, A., S. Mesaros, M. Finkel, C. Oddis, L. Birder, and T. Malinski. β-Adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes. Am. J. Physiol. Cell Physiol. 273: C1371-C1377, 1997.
28. Kaneko, H., T. Endo, K. Kiuchi, and H. Hayakawa. Inhibition of nitric oxide synthesis reduces coronary blood flow response but does not increase cardiac contractile response to β-adrenergic stimulation in normal dogs. J. Cardiovasc. Pharmacol. 27: 247-254, 1996.
29. Keaney, J. F., J. M. Hare, J.-L. Balligand, J. Loscalzo, T. W. Smith, and W. S. Colucci. Inhibition of nitric oxide synthase augments myocardial contractile responses to β-adrenergic stimulation. Am. J. Physiol. Heart Circ. Physiol. 271: H2646-H2652, 1996.
30. Kelm, M., S. Schafer, R. Dahmann, B. Dolu, S. Perings, U. Decking, J. Schrader, and B. Stauber. Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. Cardiovasc. Res. 36: 185-194, 1997.
31. G-methyl-L-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitro. Eur. J. Pharmacol. 223: 1-7, 1992.
32. Klimaschewski, L., W. Kummer, B. Mayer, J. Y. Couraud, U. Preissler, B. Philippin, and C. Heym. Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circ. Res. 71: 1533-1537, 1992.
33. Ma, J., C. Ayata, P. L. Huang, M. C. Fishman, and M. A. Moskowitz. Regional cerebral blood flow response to vibrissal stimulation in mice lacking type I NOS gene expression. Am. J. Physiol. Heart Circ. Physiol. 270: H1085-H1090, 1996.
34. Milano, C. A., L. F. Allen, H. A. Rockman, P. C. Dolber, T. R. McMinn, K. R. Chien, T. D. Johnson, R. A. Bond, and R. J. Lefkowitz. Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor [see comments]. Science 264: 582-586, 1994.
35. Mohan, P., D. Brutsaert, W. Paulus, and S. Sys. Myocardial contractile response to nitric oxide and cGMP. Circulation 93: 1223-1229, 1996.
36. Moncada, S., and A. Higgs. The L-arginine-nitric oxide pathway. N. Eng. J. Med. 329: 2002-2012, 1993.
37. Moroi, M., L. Zhang, T. Yasuda, R. Virmani, H. K. Gold, M. C. Fishman, and P. L. Huang. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J. Clin. Invest. 101: 1225-32, 1998.
38. Murohara, T., T. Asahara, M. Silver, C. Bauters, H. Masuda, C. Kalka, M. Kearney, D. Chen, J. F. Symes, M. C. Fishman, P. L. Huang, and J. M. Isner. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101: 2567-2578, 1998.
39. Okubo, T., N. Suto, S. Kudo, H. Hanada, A. Mikuniya, and K. Okumura. A study on the effects of endogenous nitric oxide on coronary blood flow, myocardial oxygen extraction and cardiac contractility. Fundam. Clin. Pharmacol. 13: 34-42, 1999.
40. Paulus, W. Paracrine coronary endothelial modulation of diastolic left ventricular function in man: implications for diastolic heart failure. J. Card. Fail. 2: S155-S164, 1996.
41. Paulus, W. J., P. J. Vantrimpont, and A. M. Shah. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation 89: 2070-2078, 1994.
42. Son, H., R. D. Hawkins, K. Martin, M. Kiebler, P. L. Huang, M. C. Fishman, and E. R. Kandel. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 87: 1015-1023, 1996.
43. Steudel, W., F. Ichinose, P. L. Huang, W. E. Hurford, R. C. Jones, J. A. Bevan, M. C. Fishman, and W. M. Zapol. Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ. Res. 81: 34-41, 1997.
44. Steudel, W., M. Scherrer-Crosbie, K. D. Bloch, J. Weimann, P. L. Huang, R. C. Jones, M. H. Picard, and W. M. Zapol. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J. Clin. Invest. 101: 2468-2477, 1998.
45. Stoyanovski, D., T. Murphy, P. Anno, Y. Kim, and G. Salama. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21: 19-29, 1997.
46. Thorin, E., P. L. Huang, M. C. Fishman, and J. A. Bevan. Nitric oxide inhibits α2-adrenoceptor-mediated endothelium-dependent vasodilation. Circ. Res. 82: 1323-1329, 1998.
47. Vandecasteele, G., T. Eschenhagen, H. Scholz, B. Stein, I. Verde, and R. Fischmeister. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat. Med. 5: 331-334, 1999.
48. Xu, L., J. Eu, G. Meissner, and J. Stamler. Activation of cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279: 234-237, 1998.
49. Yamamoto, K., J. C. Burnett, Jr, and M. Redfield. Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Am. J. Physiol. Heart Circ. Physiol. 273: H2406-H2414, 1997.